Search research articles
Contact Us
Filters
Showing results (151-160 of 243) with videos related to
Page
of 25
Sort By:
Annals of Neurology
|
February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma
Ulrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2014
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks, Veronika Dunkl, Gabriele Stoffels, et al.
Neurology
|
September 29, 2020
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
Sabine Seidel, Hendrik Pels, Sabine Schlömer, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 6, 2021
Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status
Matthias Schneider, Anna-Laura Potthoff, Bernd O Evert, et al.
Neurology
|
February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma
Agnieszka Korfel, Eckhard Thiel, Peter Martus, et al.
Journal of Neuro-Oncology
|
June 15, 2022
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS
Johannes Weller, Niklas Schäfer, Christina Schaub, et al.
Neuro-Oncology
|
March 2, 2023
Targeted anticonvulsive treatment of IDH-wildtype glioblastoma based on DNA methylation subclasses
Richard Drexler, Jennifer Göttsche, Thomas Sauvigny, et al.
Neurosurgical Review
|
May 14, 2021
Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom
Majd Bahna, Muriel Heimann, Christian Bode, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 10, 2025
Intraoperative radiotherapy for resectable brain metastases: a systematic review and meta-analysis
Cas Stefaan Dejonckheere, Matthias Schneider, Anna-Laura Potthoff, et al.
Page
of 25
Search research articles
Search
Showing results (151-160 of 243) with videos related to
Sort By:
Page
of 25
Annals of Neurology
|
February 9, 2002
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma
Ulrich Herrlinger, Martin Schabet, Wolfram Brugger, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 21, 2014
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks, Veronika Dunkl, Gabriele Stoffels, et al.
Neurology
|
September 29, 2020
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
Sabine Seidel, Hendrik Pels, Sabine Schlömer, et al.
Pharmaceuticals (Basel, Switzerland)
|
March 6, 2021
Inhibition of Intercellular Cytosolic Traffic via Gap Junctions Reinforces Lomustine-Induced Toxicity in Glioblastoma Independent of MGMT Promoter Methylation Status
Matthias Schneider, Anna-Laura Potthoff, Bernd O Evert, et al.
Neurology
|
February 27, 2015
Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma
Agnieszka Korfel, Eckhard Thiel, Peter Martus, et al.
Journal of Neuro-Oncology
|
June 15, 2022
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS
Johannes Weller, Niklas Schäfer, Christina Schaub, et al.
Neuro-Oncology
|
March 2, 2023
Targeted anticonvulsive treatment of IDH-wildtype glioblastoma based on DNA methylation subclasses
Richard Drexler, Jennifer Göttsche, Thomas Sauvigny, et al.
Neurosurgical Review
|
May 14, 2021
Tumor-associated epilepsy in patients with brain metastases: necrosis-to-tumor ratio forecasts postoperative seizure freedom
Majd Bahna, Muriel Heimann, Christian Bode, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET
Jan-Michael Werner, Johannes Weller, Garry Ceccon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 10, 2025
Intraoperative radiotherapy for resectable brain metastases: a systematic review and meta-analysis
Cas Stefaan Dejonckheere, Matthias Schneider, Anna-Laura Potthoff, et al.
Page
of 25